CH:ENM Stock Latest News
Company AnnouncementsCASI Pharmaceuticals Nets $5.9 Million From Sale of Alesta Stake to BioMarin2M ago6K
Company AnnouncementsCASI Pharmaceuticals Posts First-Half 2026 Results, Advances CID-103 After Nasdaq Delisting2M ago6K
Company AnnouncementsCASI Pharmaceuticals Continues U.S. Streamlining With Senior Vice President Departure2M ago6K
Company AnnouncementsCASI Pharmaceuticals Rescinds Evomela License Termination in Settlement With Acrotech4M ago6K
Company AnnouncementsCASI Pharmaceuticals Director Resigns but Stays On as Consultant5M ago6K
Company AnnouncementsCASI Pharmaceuticals Delays Annual 20-F Filing6M agoCompany AnnouncementsCASI Pharmaceuticals Reshapes Medical Leadership Amid U.S. Streamlining Drive6M ago6K
Company AnnouncementsCASI Pharmaceuticals Closes Final US$5 Million Tranche of US$20 Million Convertible Notes6M ago6K
Company AnnouncementsCASI Pharmaceuticals Begins Trading on OTCQB Under Ticker CASIF6M ago6K
Company AnnouncementsCASI Pharmaceuticals CEO David Cory to Step Down; Executive Chairman Wei-Wu He Assumes Top Role8M ago6K- Company AnnouncementsCASI Pharmaceuticals to Be Delisted From Nasdaq, Shares Expected to Move to OTC Market8M ago6KCASI
Company AnnouncementsCASI Pharmaceuticals Names New Executive Chairman, Streamlines U.S. Operations Amid Listing Pressure8M ago6KCASI- Company AnnouncementsCASI Pharmaceuticals Secures China Drug Registration for Thiotepa Ahead of Planned Asset Disposal8M ago6KCASI
Company AnnouncementsCASI Pharmaceuticals Fails to Renew FOLOTYN Import License in China, Halts Sales9M ago6KCASI
Company AnnouncementsCASI Pharmaceuticals Closes Second Tranche of US$20 Million Convertible Note Financing9M ago6KCASICompany AnnouncementsCASI Pharmaceuticals Closes First US$5 Million Tranche of Convertible Note Financing10M ago6KCASI